Tidemark’s Labcorp LH Stock Holding History

Tidemark’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.35K	Buy	12 +1	+9%	+$263	﹤0.01%	642
2026 Q1	$2.92K	Buy	+11	New	+$2.98K	﹤0.01%	617

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Tidemark's LH Position: Q2 2026 in Review

Tidemark increased its Labcorp (LH) stake by 9.1% in Q2 2026, buying an estimated $263 and bringing the position to 12 shares worth $3.35K. The position accounts for ﹤0.01% of the portfolio, ranked #642.

Tidemark first reported a position in LH in Q1 2026 and has held it in 2 quarters since. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Tidemark held 12 shares of Labcorp worth $3.35K as of Q2 2026.
Tidemark bought 1 Labcorp share in Q2 2026, an estimated $263.
Labcorp made up ﹤0.01% of Tidemark's portfolio in Q2 2026, its #642 holding.
Tidemark first reported a position in Labcorp in Q1 2026 and has held it in 2 quarters since.
1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.